Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Formaat: Artigo
Taal:Russo
Gepubliceerd in: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Reeks:Vestnik Transplantologii i Iskusstvennyh Organov
Onderwerpen:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Online toegang:https://journal.transpl.ru/vtio/article/view/1194
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items